Literature DB >> 9864404

Prospective study of nonsteroidal anti-inflammatory drugs and breast cancer.

R E Harris1, S Kasbari, W B Farrar.   

Abstract

We conducted a prospective cohort study of Nonsteroidal anti-inflammatory drugs (NSAIDs) and breast cancer among 32,505 women in central Ohio, USA. After 5 years of follow-up, a total of 393 cases have been detected. The annual incidence of breast cancer per 100,00 women varied inversely with increasing intake of NSAIDs, declining from 323 among non-users to 183 among heavy users (p<0.01). Breast cancer rates decreased by about 50% with regular ibuprofen intake (p<0.01), and by about 40% with regular aspirin intake (p<0.05). The results suggest that specific NSAIDs may be effective chemopreventive agents against breast cancer.

Entities:  

Mesh：

Substances：

Year:  1999        PMID： 9864404

Source DB:  PubMed          Journal:  Oncol Rep        ISSN： 1021-335X            Impact factor:   3.906


  35 in total

1.  Modulation of breast cancer risk by nonsteroidal anti-inflammatory drugs.

Authors:  Louise R Howe; Scott M Lippman
Journal:  J Natl Cancer Inst       Date:  2008-10-07       Impact factor: 13.506

2.  Nonsteroidal anti-inflammatory drugs and change in mammographic density: a cohort study using pharmacy records on over 29,000 postmenopausal women.

Authors:  Mary Beth Terry; Diana S M Buist; Amy Trentham-Dietz; Tamarra M James-Todd; Yuyan Liao
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2008-05       Impact factor: 4.254

3.  Anesthetic drug propofol inhibits the expression of interleukin-6, interleukin-8 and cyclooxygenase-2, a potential mechanism for propofol in suppressing tumor development and metastasis.

Authors:  Xuefeng Li; Longyun Li; Feng Liang; Guifeng Liu; Guoqing Zhao
Journal:  Oncol Lett       Date:  2018-04-17       Impact factor: 2.967

Review 4.  [Epidemiological studies for evaluating the role of cyclooxygenase in chemoprevention of malignant tumors].

Authors:  Eva S Schernhammer; Christian Dittrich
Journal:  Wien Med Wochenschr       Date:  2003

5.  An overview of clinical pharmacology of Ibuprofen.

Authors:  Rabia Bushra; Nousheen Aslam
Journal:  Oman Med J       Date:  2010-07

6.  Use of aspirin, other nonsteroidal anti-inflammatory drugs, and acetaminophen and risk of breast cancer among premenopausal women in the Nurses' Health Study II.

Authors:  A Heather Eliassen; Wendy Y Chen; Donna Spiegelman; Walter C Willett; David J Hunter; Susan E Hankinson
Journal:  Arch Intern Med       Date:  2009-01-26

7.  Effects of a cyclooxygenase-1-selective inhibitor in a mouse model of ovarian cancer, administered alone or in combination with ibuprofen, a nonselective cyclooxygenase inhibitor.

Authors:  Wei Li; Ru-Jun Xu; Zhen-Yun Lin; Guang-Chao Zhuo; Hong-He Zhang
Journal:  Med Oncol       Date:  2008-11-06       Impact factor: 3.064

8.  Prescriptions for selective cyclooxygenase-2 inhibitors, non-selective non-steroidal anti-inflammatory drugs, and risk of breast cancer in a population-based case-control study.

Authors:  Deirdre P Cronin-Fenton; Lars Pedersen; Timothy L Lash; Søren Friis; John A Baron; Henrik T Sørensen
Journal:  Breast Cancer Res       Date:  2010-03-01       Impact factor: 6.466

9.  A large cohort study of nonsteroidal anti-inflammatory drug use and melanoma incidence.

Authors:  Maryam M Asgari; Sonia S Maruti; Emily White
Journal:  J Natl Cancer Inst       Date:  2008-06-24       Impact factor: 13.506

10.  Use of aspirin, other nonsteroidal anti-inflammatory drugs, and acetaminophen and postmenopausal breast cancer incidence.

Authors:  Xuehong Zhang; Stephanie A Smith-Warner; Laura C Collins; Bernard Rosner; Walter C Willett; Susan E Hankinson
Journal:  J Clin Oncol       Date:  2012-08-27       Impact factor: 44.544
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.